l-Thyroxine is converted to 3,5,3′-l-triiodothyronine (T3) as well as to 3,3′,5′-l-triiodothyronine (reverse T3). One product of further deiodination is 3,3′-diiodothyronine (3,3′T2). The serum levels of reverse T3 and 3,3′T2 change considerably in various physiological and disease states. We previously found that reverse T3 and 3,3′T2 bind to the solubilized hepatic nuclear “receptors” for thyroid hormones. This led us to study binding and actions of these metabolites in cultured rat pituitary cells in which glucose consumption and growth hormone production are regulated by T3 and l-thyroxine.
Stathis S. Papavasiliou, Joseph A. Martial, Keith R. Latham, John D. Baxter
Usage data is cumulative from May 2024 through May 2025.
Usage | JCI | PMC |
---|---|---|
Text version | 196 | 7 |
49 | 16 | |
Scanned page | 392 | 3 |
Citation downloads | 73 | 0 |
Totals | 710 | 26 |
Total Views | 736 |
Usage information is collected from two different sources: this site (JCI) and Pubmed Central (PMC). JCI information (compiled daily) shows human readership based on methods we employ to screen out robotic usage. PMC information (aggregated monthly) is also similarly screened of robotic usage.
Various methods are used to distinguish robotic usage. For example, Google automatically scans articles to add to its search index and identifies itself as robotic; other services might not clearly identify themselves as robotic, or they are new or unknown as robotic. Because this activity can be misinterpreted as human readership, data may be re-processed periodically to reflect an improved understanding of robotic activity. Because of these factors, readers should consider usage information illustrative but subject to change.